Veracyte Inc - ESG Rating & Company Profile powered by AI
This page displays a free Environmental, Social and Governance analysis covering Veracyte Inc. Other companies in the rating industry group for Veracyte Inc are displayed. The analysis of Veracyte Inc was prepared by All Street Sevva using leading artificial intelligence.
Veracyte Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.9; made up of an environmental score of 2.7, social score of 3.4 and governance score of 2.7.
2.9
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1336 | SyneuRx International (Taiwan) Corp | 3.0 | Medium |
1336 | Sensorion SA | 3.0 | Medium |
1353 | Veracyte Inc | 2.9 | Medium |
1353 | Caribou Biosciences Inc | 2.9 | Medium |
1353 | Checkmate Pharmaceuticals Inc | 2.9 | Medium |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |
Frequently Asked Questions
Does Veracyte Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Veracyte Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Veracyte Inc report the average age of the workforce?
Sign up for free to unlockDoes Veracyte Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Veracyte Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Veracyte Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Veracyte Inc offer flexible work?
Sign up for free to unlockDoes Veracyte Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Veracyte Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Veracyte Inc conduct supply chain audits?
Sign up for free to unlockDoes Veracyte Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Veracyte Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Veracyte Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Veracyte Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Veracyte Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Veracyte Inc disclose water use targets?
Sign up for free to unlockDoes Veracyte Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Veracyte Inc have a product recall in the last two years?
Sign up for free to unlockDoes Veracyte Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Veracyte Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Veracyte Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Veracyte Inc disclose parental leave metrics?
Sign up for free to unlockDoes Veracyte Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Veracyte Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Veracyte Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Veracyte Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Veracyte Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Veracyte Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Veracyte Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Veracyte Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Veracyte Inc disclose its waste policy?
Sign up for free to unlockDoes Veracyte Inc report according to TCFD requirements?
Sign up for free to unlockDoes Veracyte Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Veracyte Inc disclose energy use targets?
Sign up for free to unlockDoes Veracyte Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Veracyte Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Veracyte Inc
These potential risks are based on the size, segment and geographies of the company.
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Genomic Sequencing Classifier and Percepta Nasal Swab Test for lung cancer diagnosis; Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis; and Immunoscore Colon Cancer test for colon cancer diagnosis. It is also developing Percepta Genomic Atlas to help inform lung cancer treatment decisions; Envisia Classifier, the nCounter analysis system; and LymphMark for lymphoma subtyping test. Veracyte, Inc. has technology licensing and collaboration arrangements with Johnson & Johnson; Acerta Pharma; and CareDx. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.